The evidence should establish what is being challenged
I would select a defined diagnosis-related population and review payer letters alongside the clinical documentation, coding history, and appeal outcomes with the appropriate experts. The aim is to separate a coding interpretation, a request for missing information, and a challenge to the clinical support for a diagnosis. A broad denial category may combine several of those problems.
The clinical and CDI owners should determine which documentation opportunities are actionable and which payer conclusions warrant disagreement. I would not convert every denied diagnosis into a template change. Some cases may already contain the necessary evidence, while others need a better way to explain clinical reasoning or resolve conflicting documentation.
The review should retain the evidence behind each finding. That includes the payer's stated rationale, the documentation element requiring attention, and the owner who validated the interpretation. A recommendation grounded in those examples is more useful than a general instruction to document more thoroughly.
The template should prompt an accurate account of the patient
I would work with clinical, CDI, and coding leaders to define what the documentation tool should help the provider express. That can include the relevant assessment, supporting findings, important relationships, and the reasoning for the documented diagnosis. The content should reflect approved clinical practice and the actual record, not a default statement chosen to protect a particular DRG.
In Epic, a SmartPhrase or SmartText can make the agreed prompts easier to use. SmartLists can offer structured choices, and appropriate SmartLinks can bring relevant chart information into the note. Each inserted value still needs clinical interpretation. A table of laboratory results is not equivalent to a provider explaining what those results mean for the patient.
I would avoid defaulting every response to a positive finding or carrying forward a conclusion without review. The clinical owners need to define how uncertainty, an alternative explanation, or a condition ruled out should be documented. The tool should make an accurate response easier, including when the expected diagnosis is not supported.
A prompt, a required response, and a hard stop are different decisions
I would ask where the tool should appear and how the provider will reach it during normal documentation. A shared SmartPhrase can improve consistency when clinicians use it, but availability alone does not guarantee adoption. A template inserted into a note is also different from a workflow that automatically reacts to a diagnosis.
Requiring a SmartList response inside a template does not establish that the template appears on every qualifying encounter. Similarly, a coding validation for outstanding CDI queries is not a note-signing restriction. I would state the intended control precisely before the application team estimates or builds it.
The selection logic should match the intended population, with local version and workflow capabilities confirmed. If patient-context rules or provider nudges are considered, I would treat them as an additional design decision requiring clinical oversight and testing. They should not be assumed to exist because the organization already uses standard note templates.
CDI provides the path for records that remain unclear
I would define how a specialist identifies incomplete or conflicting information, selects an appropriate query type, sends the clarification, and follows the provider response. Query and response SmartTexts can support consistency, while the specialist remains responsible for the content of the individual request. The workflow also needs a way to document disagreement or an inability to determine the condition.
Acceptance scenarios should include a clearly supported diagnosis, a record needing clarification, a condition ruled out, copied-forward documentation, a missing data element, and a provider response through the supported mobile workflow. I would review the rendered note and the resulting clinical and coding handoffs rather than test the template in isolation.
The pilot should evaluate burden as well as completeness. If clinicians cannot find the tool, regularly select irrelevant choices, or create duplicate notes to resolve queries, the design needs attention. The approved workflow should make the clinical record clearer without creating another layer of avoidable documentation work.
The measures should connect adoption to the actual problem
I would track use of the documentation tool in the eligible population, completeness of the targeted information, and repeat clarification needs. Adoption alone is not the outcome. A frequently used template can still produce incomplete or contradictory records, so a qualified review sample is necessary.
For payer outcomes, I would measure the targeted new clinical-validation disputes by payer and service period, allowing time for adjudication. I would keep the population consistent across changes in classification and compare appeal outcomes and final losses on mature cases. A reduction in generic documentation denials may conceal a shift into another report category.
I would separate avoided new denial dollars, recovery of older balances, and actual write-offs when discussing financial benefit. The same amount should not be added several times. The strongest result shows that the clinical owners validated a recurring documentation issue, the revised workflow improved the record, and subsequent disputes declined without undermining accurate clinical judgment.